AR-36A36.11.1

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameAR-36A36.11.1
Drug Alias NameAR-003 series (ARIUS)AR-10A304.7anti-CD59 monoclonal antibodies (ARIUS)anti-CD59 mAbs (ARIUS)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD59 glycoprotein antagonists
TargetsCD59 glycoprotein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArius Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArius Research Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A